1. Von Willebrand factor in diagnostics and treatment of cardiovascular disease: Recent advances and prospects
   Sergey Kozlov et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis
   Mengge Fan et al, 2020, BMC Cardiovascular Disorders CrossRef
3. Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells
   Fengyun Dong et al, 2021, Fundamental & Clinical Pharmacology CrossRef
4. Role of von Willebrand factor in the angiogenesis of lung adenocarcinoma (Review)
   Xin Li et al, 2022, Oncology Letters CrossRef
5. Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis
   Celestina Mazzotta et al, 2024, Thrombosis Research CrossRef
6. GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature
   Yinghua Xu et al, 2017, Oncotarget CrossRef
7. Plasma VWF: Ag levels predict long-term clinical outcomes in patients with acute myocardial infarction
   Zulipiyemu Xier et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
8. Regulation of von Willebrand factor expression
   Elham Ghorbanpour et al, 2024, Textbook of von Willebrand Disease CrossRef
9. Hemodynamic activation of von Willebrand factor in children with congenital heart diseases
   K. A. Tokmakova et al, 2024, Obstetrics, Gynecology and Reproduction CrossRef
10. Venous gas emboli are involved in post-dive macro, but not microvascular dysfunction
    Kate Lambrechts et al, 2017, European Journal of Applied Physiology CrossRef
11. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology
    Sergey Okhota et al, 2020, International Journal of Molecular Sciences CrossRef
12. Intracellular receptor EPAC regulates von Willebrand factor secretion from endothelial cells in a PI3K-/eNOS-dependent manner during inflammation
    Jie Xiao et al, 2021, Journal of Biological Chemistry CrossRef
13. Cadmium, von Willebrand factor and vascular aging
    Xia Wang et al, 2023, npj Aging CrossRef
14. Palmitate Stimulates Expression of the von Willebrand Factor and Modulates Toll-like Receptors Level and Activity in Human Umbilical Vein Endothelial Cells (HUVECs)
    Agnieszka K. Seliga et al, 2023, International Journal of Molecular Sciences CrossRef
15. Glycosylation changes of vWF in circulating extracellular vesicles to predict depression
    Norihiro Yamada et al, 2024, Scientific Reports CrossRef
16. Plasma von Willebrand factor levels in patients with cancer: A meta‑analysis
    Xitan Wang et al, 2024, Oncology Letters CrossRef
17. Plasma levels of von Willebrand factor in type 2 diabetes patients with and without cardiovascular diseases: A meta‐analysis
    Xun Peng et al, 2020, Diabetes/Metabolism Research and Reviews CrossRef
18. Modular 3D In Vitro Artery-Mimicking Multichannel System for Recapitulating Vascular Stenosis and Inflammation
    Minkyung Cho et al, 2021, Micromachines CrossRef
19. Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells
    Nikolett Wohner et al, 2022, Journal of Thrombosis and Haemostasis CrossRef
20. Platelet adhesion mediated by von Willebrand factor in patients with premature coronary artery disease
    S. D. Okhota et al, 2023, Kardiologiia CrossRef
21. Cadmium regulates von Willebrand factor and occludin expression in glomerular endothelial cells of mice in a TNF-α-dependent manner
    Zongguo Sun et al, 2019, Renal Failure CrossRef